Gvb Biopharma reported raising $1 Million in an initial SEC Form D filing, from an offering of $1 Million
Amount Raised
$1 Million
Round Type
Seed
Las VegasManufacturingAgriculture And FarmingQuick answer
GVB Biopharma raised $1 Million in a Seed round, dated May 19, 2022. GVB Biopharma is based in Las Vegas, Nevada, United States.
- How much did GVB Biopharma raise?
- GVB Biopharma raised $1 Million in a Seed round on May 19, 2022.
- What does GVB Biopharma do?
- Founded in 2016, GVB is one of the world’s leading innovators in hemp technology.
- Where is GVB Biopharma based and how big is it?
- GVB Biopharma is based in Las Vegas, Nevada, United States.
Source: Fundz verified event record.
Who else raised in Agriculture And Farming and Manufacturing around the same time
Companies in the same sectors as GVB Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Hadrian raised $11M (Seed) on June 24, 2022.
- Hadrian raised $37M on April 15, 2022.
- WEG raised $128K on July 1, 2022.
- Ascendia Pharmaceuticals raised $2.5M on July 1, 2022.
- Cognito Therapeutics raised $53M on July 1, 2022.
- Ripelocker raised $2.3M (Seed) on July 1, 2022.
Who to call at GVB Biopharma, and when
A new round usually means GVB Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GVB Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GVB Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GVB Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GVB Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GVB Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.